Fulgent Genetics is a biotechnology company that specializes in genomic testing and diagnostics, providing a wide range of services geared toward enhancing patient care
They focus on offering comprehensive genetic testing solutions that help identify genetic disorders, infectious diseases, and hereditary conditions. Utilizing advanced technology and innovative methodologies, Fulgent Genetics aims to improve clinical decision-making, facilitate personalized medicine, and support the research community in understanding complex genetic information. Their services cater to healthcare providers, patients, and laboratories, making genomic testing more accessible and streamlined.
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Companies Reporting Before The Bell • CNH Industrial (NYSECNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion.
